grant

Understanding the relationship between cortical hyperexcitability and the progression of FTD/ALS pathology and behavioral deficits in mice

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 1 Sept 2024Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY2025AD dementiaALS pathologyALS patientsAddressAffectAgeAgingAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAmyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis Motor Neuron DiseaseAmyotrophic Lateral Sclerosis patientsAmyotrophic lateral sclerosis and frontotemporal degenerationAmyotrophic lateral sclerosis and frontotemporal dementiaAnesthesiaAnesthesia proceduresAnimal ModelAnimal Models and Related StudiesAppearanceApplications GrantsAwardBehaviorBehavioralBusiness-Friendly AtmosphereC9ORF72CalciumChronicCognitive deficitsComplementComplement ProteinsCytoplasmic InclusionDataDegenerative Neurologic DisordersDevelopmentDevelopment PlansDipeptidesDisease ProgressionDysfunctionEducational workshopElectrophysiologyElectrophysiology (science)EnsureEnvironmentEquilibriumFTD dementiaFTD/ALSFTLD/ALSFrontal Temporal DementiaFrontotemporal DementiaFrontotemporal Lobar Degeneration/Amyotrophic lateral sclerosisFunctional disorderGehrig's DiseaseGeneral HospitalsGenesGeneticGoalsGrantGrant ProposalsHyperactivityImageIndividualInterventionInvestigatorsKnowledgeKnowledge acquisitionLaboratoriesLeadershipLearningLou Gehrig DiseaseManuscriptsMassachusettsMeasuresMentorsMentorshipMiceMice MammalsModelingMonitorMotor Neuron DiseaseMurineMusNerve CellsNerve UnitNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural degenerative DisordersNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNeuronsNeurophysiology / ElectrophysiologyNon-Polyadenylated RNANuclear RNAOnset of illnessPathologicPathologyPatientsPersonalityPhenotypePhysiopathologyPlacebosPrimary Senile Degenerative DementiaProteinsProxyR-Series Research ProjectsR01 MechanismR01 ProgramRNARNA Gene ProductsReportingResearchResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearch ResourcesResearchersResourcesRibonucleic AcidSham TreatmentTAR DNA-binding protein 43TDP-43TDP43Teaching HospitalsTechnologyTestingTrainingValidationWorkshopage associated effectsage effectage related effectsaged miceaged mouseagesaging effectamyotrophic lateral sclerosis pathologyamyotrophic lateral sclerosis with frontotemporal dementiaamyotrophic lateral sclerosis/FTLDamyotrophic lateral sclerosis/frontotemporal dementiaamyotrophic lateral sclerosis/ftdawakebalancebalance functionbehavior changebehavior phenotypebehavioral phenotypingbrain tissuebusiness-friendly environmentcareercareer developmentcell typechromosome 9 open reading frame 72co-morbidco-morbiditycognitive defectscollaborative atmospherecollaborative environmentcomorbiditycomplementationconferenceconventiondegenerative diseases of motor and sensory neuronsdegenerative disorder of motor neuronsdegenerative neurological diseasesdesigndesigningdevelop therapydevelopmentaldisease onsetdisorder onseteffective therapyeffective treatmentelderly miceelectrical measurementelectrophysiologicalexperimentexperimental researchexperimental studyexperimentsfront temporal dementiafrontal lobe dementiafrontotemporal dementia-amyotrophic lateral sclerosisfrontotemporal lobar degeneration dementiafrontotemporal lobar dementiafrontotemporal lobar dementia amyotrophic lateral sclerosisfrontotemporal lobe degeneration associated with dementiagenetic approachgenetic strategyimagingimaging studyimpact of agein vivoinfluence of ageinsightinteractive atmosphereinteractive environmentinterdisciplinary atmosphereinterdisciplinary environmentintervention developmentlongitudinal imagingmeasurement of electrical propertiesmedical collegemedical schoolsmeetingmeetingsmodel of animalmouse modelmulti-photonmulti-photon imagingmultiphoton excitation microscopymultiphoton imagingmultiphoton microscopymurine modelnerve cell deathnerve cell lossneurodegenerative illnessneuron cell deathneuron cell lossneuron deathneuron lossneuronalneuronal cell deathneuronal cell lossneuronal deathneuronal excitabilityneuronal lossneuropathologicneuropathologicalneuropathologynew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapy approachesnew treatment approachnew treatment strategynovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapy approachold miceoptogeneticspathology in ALSpathophysiologypeer-group atmospherepeer-group environmentprimary degenerative dementiaprogramsprotein TDP-43protein TDP43school of medicinesenile dementia of the Alzheimer typeserial imagingsham therapyskill acquisitionskill developmentskillssummitsymposiasymposiumtherapy developmenttooltreatment developmentvalidations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Frontotemporal dementia (FTD) is a progressive neurodegenerative disorder that causes severe
personality and behavior changes. A hexanucleotide repeat expansion in the C9orf72 gene is

FTD's most common genetic cause. I aim to elucidate the mechanisms of circuit dysfunction in

C9orf72-FTD, focusing on understanding the relationship between cortical hyperactivity, the

progression of C9orf72 hexanucleotide repeat pathology, and behavior. Understanding these

aspects is crucial for developing effective and timely treatments for FTD.

The first aim of this research is to monitor the progression of neuronal activity during critical age

in a robust animal model of FTD and evaluate its relationship to neuronal loss. In the second

aim, I will determine whether neuronal hyperactivity can causally drive the progression of FTD

pathology and behavioral deficits. I will then test the effect of restoring neuronal activity by

modulating the balance between excitation and inhibition on pathology and behavioral deficits in

a C9orf72-FTD model. I will capitalize on my expertise in state-of-the-art technology, such as

multiphoton microscopy, optogenetics, and chemogenetics while acquiring knowledge and skills

in FTD research, FTD animal models, and electrophysiology.

A team of renowned experts in the field will provide mentorship to guide me through specialized

training and ensure the establishment of an independent research career in the FTD field. The

career development plan includes attending laboratory meetings and departmental discussions,

national conferences, crafting research grant proposals, and preparing manuscripts. The

training will take place at Massachusetts General Hospital (MGH), a prominent teaching hospital

affiliated with Harvard Medical School (HMS). MGH is renowned for its supportive research

environment, advanced resources, and collaborative atmosphere conducive to learning and

research in neurodegenerative diseases. Furthermore, MGH and HMS will facilitate my

professional development by granting me access to various courses and workshops to enhance

my presentation, leadership, and management skills.

In summary, this award will prepare me to lead a research lab, ensuring successful

electrophysiology and FTD/ALS training and an efficient transition to an independent career.

Grant Number: 5K99AG088296-02
NIH Institute/Center: NIH

Principal Investigator: Moustafa Algamal

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →